Immunopharmacological Activity of Betulin in Inflammation-associated Carcinogenesis

Author(s): Anja Schwiebs*, Heinfried H. Radeke

Journal Name: Anti-Cancer Agents in Medicinal Chemistry
(Formerly Current Medicinal Chemistry - Anti-Cancer Agents)

Volume 18 , Issue 5 , 2018

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


This review highlights the multiple properties of the birch bark-derived pentacyclic triterpene betulin with special focus on its pharmacological activity in cancer and inflammation. While less well characterized compared to its hydrophilic derivative, betulinic acid, it exhibits potent anticancer activity described in many publications. Indeed, underinvestigated are its immunomodulatory functions in inflammatory diseases that appeared to enhance innate immune cell activities in an adjuvant-like fashion towards an interleukin-12 driven antitumor immunity. Herein, we like to emphasize the simultaneous and dual function of betulin on the basis of recent investigations of the tumor microenvironment and enlighten the potential use of betulin in the control of inflammation-associated carcinogenesis.

Keywords: Pentacyclic triterpene, betulin, dendritic cell, inflammation-associated carcinogenesis, cytostatic, immunomodulation.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2018
Page: [645 - 651]
Pages: 7
DOI: 10.2174/1871520617666171012124820
Price: $65

Article Metrics

PDF: 42
PRC: 1